Difference between revisions of "Thoracic SMARCA4-deficient undifferentiated tumour"
Jump to navigation
Jump to search
(create) |
|||
| Line 1: | Line 1: | ||
'''Thoracic SMARCA4-deficient undifferentiated tumour''' is poorly differentiated malignancy of the thorax.<ref>{{cite journal |authors=Shinno Y, Ohe Y |title=Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives |journal=Jpn J Clin Oncol |volume=54 |issue=3 |pages=265–270 |date=March 2024 |pmid=38117955 |doi=10.1093/jjco/hyad175 |url=}}</ref> | '''Thoracic SMARCA4-deficient undifferentiated tumour''' is poorly differentiated malignancy of the thorax.<ref>{{cite journal |authors=Shinno Y, Ohe Y |title=Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives |journal=Jpn J Clin Oncol |volume=54 |issue=3 |pages=265–270 |date=March 2024 |pmid=38117955 |doi=10.1093/jjco/hyad175 |url=}}</ref> | ||
==Microscopic== | |||
Features: | |||
*Poorly differentiated malignancy. | |||
*+/-[[Rhabdoid morphology]]. | |||
==IHC== | |||
*SMARCA4 loss or strongly reduced (definitional). | |||
*AE1/AE3 -ve or focal. | |||
*Synaptophysin +ve. | |||
*Chromogranin -ve. | |||
==See also== | |||
*[[SMARCA4]]. | |||
==References== | ==References== | ||
Revision as of 19:46, 21 August 2025
Thoracic SMARCA4-deficient undifferentiated tumour is poorly differentiated malignancy of the thorax.[1]
Microscopic
Features:
- Poorly differentiated malignancy.
- +/-Rhabdoid morphology.
IHC
- SMARCA4 loss or strongly reduced (definitional).
- AE1/AE3 -ve or focal.
- Synaptophysin +ve.
- Chromogranin -ve.
See also
References
- ↑ Shinno Y, Ohe Y (March 2024). "Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives". Jpn J Clin Oncol 54 (3): 265–270. doi:10.1093/jjco/hyad175. PMID 38117955.